Larry D. Anderson, MD, PhD, FACP

Biography

Larry D. Anderson Jr, MD, PhD, FACP, is a Professor at UT Southwestern Medical Center and Director of the Myeloma, Waldenström's, and Amyloidosis Program at Simmons Comprehensive Cancer Center. He also leads the Hematologic Malignancies and Cellular Therapy Clinical Research Program and is the Co-Director of the Phase I Clinical Trial Research Program. In 2000, Dr. Anderson earned both his MD at McGovern Medical School and his PhD in cancer immunology from MD Anderson Cancer Center and UT Health Houston. He completed an internship and residency in internal medicine at the Mayo Clinic in Rochester, MN, followed by a fellowship in medical oncology at the University of Washington Medical Center and Fred Hutchinson Cancer Research Center before joining the UT Southwestern faculty in 2008. Dr. Anderson specializes in the treatment of plasma cell disorders such as Multiple Myeloma, Waldenström's Macroglobulinemia, and AL Amyloidosis. He has a particular interest in CAR T-cell therapy and clinical trials of immunotherapy. He serves on the NCCN Guidelines Panel for plasma cell disorders and on the ASTCT’s Cellular Therapy Committee. He runs an active clinical trial research program that has been a lead enrolling site for many practice-changing myeloma clinical trials (including KarMMa, GRIFFIN, DETERMINATION, and IMMagine-1), which has helped his program become a world-class center of excellence for plasma cell disorders.